Healthequity (NASDAQ:HQY) posted its quarterly earnings results on Tuesday. The company reported $0.22 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.20 by $0.02, Morningstar.com reports. Healthequity had a net margin of 24.52% and a return on equity of 12.93%. The business had revenue of $70.50 million during the quarter, compared to analyst estimates of $69.60 million. During the same period in the previous year, the business posted $0.17 EPS. The company’s quarterly revenue was up 24.1% on a year-over-year basis. Healthequity updated its FY 2019 guidance to $1.06-1.13 EPS and its FY19 guidance to $1.03-1.09 EPS.
Healthequity stock opened at $83.60 on Thursday. The stock has a market cap of $5.19 billion, a price-to-earnings ratio of 154.81, a PEG ratio of 2.90 and a beta of 1.37. Healthequity has a 52-week low of $42.92 and a 52-week high of $101.58.
Several research analysts have recently commented on HQY shares. SunTrust Banks lifted their price target on shares of Healthequity to $105.00 and gave the company a “buy” rating in a report on Wednesday, September 5th. Citigroup reaffirmed a “buy” rating and issued a $110.00 price target on shares of Healthequity in a report on Wednesday, September 5th. BidaskClub lowered shares of Healthequity from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 9th. ValuEngine lowered shares of Healthequity from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. Finally, Zacks Investment Research lowered shares of Healthequity from a “buy” rating to a “hold” rating in a research note on Tuesday, November 20th. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $93.23.
Several hedge funds have recently added to or reduced their stakes in HQY. Advisors Asset Management Inc. raised its position in shares of Healthequity by 5,212.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 72,086 shares of the company’s stock worth $160,000 after buying an additional 70,729 shares in the last quarter. Meeder Asset Management Inc. bought a new stake in shares of Healthequity during the 3rd quarter worth about $172,000. Cerebellum GP LLC bought a new stake in shares of Healthequity during the 3rd quarter worth about $185,000. Sawtooth Solutions LLC bought a new stake in shares of Healthequity during the 2nd quarter worth about $207,000. Finally, Cambridge Investment Research Advisors Inc. bought a new stake in shares of Healthequity during the 3rd quarter worth about $210,000. Institutional investors own 93.01% of the company’s stock.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Article: Risk Tolerance and Your Investment Decisions
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.